期刊文献+

The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancer 被引量:1

The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancer
下载PDF
导出
摘要 Recently, there has been controversy about the relationship between the number of lymph nodes removed and survival of patients diagnosed with lymph node-negative breast cancer. To assess this relationship, 603 cases of lymph node-negative breast cancer with a median of 126 months of follow-up data were studied. Patients were stratified into two groups(Group A, 10 or fewer tumor-free lymph nodes removed; Group B, more than 10 tumor-free lymph nodes removed). The number of tumor-free lymph nodes in ipsilateral axillary resections as well as 5 other disease parameters were analyzed for prognostic value. Our results revealed that the risk of death from breast cancer was significantly associated with patient age, marital status, histologic grade, tumor size, and adjuvant therapy. The 5- and 10-year survival rates for patients with 10 or fewer tumor-free lymph nodes removed was 88.0% and 66.4%, respectively, compared with 69.2% and 51.1%, respectively, for patients with more than 10 tumor-free lymph nodes removed. For patients with 10 or fewer tumor-free lymph nodes removed, the adjusted hazard ratio(HR) for risk of death from breast cancer was 0.579(95% confidence interval, 0.492-0.687, P < 0.001), independent of patient age, marital status, histologic grade, tumor size, and adjuvant therapy. Our study suggests that the number of tumor-free lymph nodes removed is an independent predictor in cases of lymph node-negative breast cancer. Recently, there has been controversy about the relationship between the number of lymph nodes removed and survival of patients diagnosed with lymph node-negative breast cancer. To assess this relationship, 603 cases of lymph node-negative breast cancer with a median of 126 months of follow-up data were studied. Patients were stratified into two groups(Group A, 10 or fewer tumor-free lymph nodes removed; Group B, more than 10 tumor-free lymph nodes removed). The number of tumor-free lymph nodes in ipsilateral axillary resections as well as 5 other disease parameters were analyzed for prognostic value. Our results revealed that the risk of death from breast cancer was significantly associated with patient age, marital status, histologic grade, tumor size, and adjuvant therapy. The 5- and 10-year survival rates for patients with 10 or fewer tumor-free lymph nodes removed was 88.0% and 66.4%, respectively, compared with 69.2% and 51.1%, respectively, for patients with more than 10 tumor-free lymph nodes removed. For patients with 10 or fewer tumor-free lymph nodes removed, the adjusted hazard ratio(HR) for risk of death from breast cancer was 0.579(95% confidence interval, 0.492-0.687, P 〈 0.001), independent of patient age, marital status, histologic grade, tumor size, and adjuvant therapy. Our study suggests that the number of tumor-free lymph nodes removed is an independent predictor in cases of lymph node-negative breast cancer.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2014年第11期569-573,共5页
基金 supported by a grant from the National Natural Science Foundation of China (No. 81172165)
关键词 淋巴结肿大 乳腺癌 肿瘤 阴性 预后 辅助治疗 置信区间 预测因子 Number,tumor-free,axillary lymph nodes,prognostic parameter,lymph node-negative,breast cancer
  • 相关文献

参考文献25

  • 1Camp RL, Rimm ED, Rimm DL. A high number of tumor-free lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer, 2000, 88:108-113.
  • 2Sosa JA, Diener-West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival of patients with stage I breast cancer. Ann Surg Oncol, 1998,5:140-149.
  • 3Moorman PG, Hamza A, Marks JR, et al. Prognostic significance of the number of lymph nodes examined in patients with lymph-node negative breast carcinoma. Cancer, 2001,91:2258-2262.
  • 4Polednak AP. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg, 2003, 237:163-167.
  • 5Carriaga MT, Henson DE. The histologic grading of cancer. Cancer, 1995,75:406-421.
  • 6Weir L, Speers C, D'yachkova Y, et al. Prognostic significance of the number of axillary lymph nodes removed in patients with node- negative breast cancer. J Clin Qncol, 2002,20:1793-1799.
  • 7Fritz A. The SEER Program's commitment to data quality. J Reg Mgmt, 2001,28:35-40.
  • 8Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer, 1996,77:308-314.
  • 9Kravdall O. The impact of marital status on cancer survival. Soc Sci Med, 2001,52:357-368.
  • 10Greco M, Agresti R, Cascinelli N, et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg, 2000,232:1-7.

同被引文献24

  • 1Armando E. Giuliano,Linda McCall,Peter Beitsch,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Kelly K. Hunt,Monica Morrow,Karla Ballman.Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial[J]. Annals of Surgery . 2010 (3)
  • 2Boughey JC,Suman VJ,Mitlendorf EA,et al.Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with nodepositive breast cancer;the ACOSOG Z107I (Alliance)clinical trial. The Journal of The American Medical Association . 2013
  • 3HIRAM S. CODY,RUEDI A. EGELI,JEROME A. URBAN.??Rotter?s Node Metastases: Therapeutic and Prognostic Considerations in Early Breast Carcinoma(J)Annals of Surgery . 1984 (3)
  • 4SAUL F. LIVINGSTON,MYRON ARLEN.??The Extended Extrapleural Radical Mastectomy: Its Role in the Treatment of Carcinoma of the Breast(J)Annals of Surgery . 1974 (3)
  • 5Choi JE.The metastatic rate of internal mammary lymph nodes when metastasis of internal mammary lymph node is suspected on PET/CT. Breast Cancer . 2013
  • 6Thorsten Kuehn,Ingo Bauerfeind,Tanja Fehm,Barbara Fleige,Maik Hausschild,Gisela Helms,Annette Lebeau,Cornelia Liedtke,Gunter von Minckwitz,Valentina Nekljudova,Sabine Schmatloch,Peter Schrenk,Annette Staebler,Michael Untch.??Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study(J)Lancet Oncology . 2013 (7)
  • 7Jingyan Sun,Jian Yin,Liansheng Ning,Juntian Liu,Hong Liu,Lin Gu,Li Fu.??Clinicopathological Characteristics of Breast Cancers with Axillary Skip Metastases(J)Journal of Investigative Surgery . 2012 (1)
  • 8Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer(J)Br J Surg . 2012 (2)
  • 9Jan J. Kootstra,Josette E. H. M. Hoekstra-Weebers,Johan S. Rietman,Jakob Vries,Peter C. Baas,Jan H. B. Geertzen,Harald J. Hoekstra.??A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection(J)Annals of Surgical Oncology . 2010 (9)
  • 10Hiroyuki Takei,Masafumi Kurosumi,Takashi Yoshida,Yuko Ishikawa,Yuji Hayashi,Jun Ninomiya,Katsunori Tozuka,Hanako Oba,Kenichi Inoue,Shigenori Nagai,Yoshihiro Saito,Tomoko Kazumoto,Jun-ichi Saitoh,Toshio Tabei.??Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies(J)Breast Cancer . 2010 (1)

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部